Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen Wins EU Approval to Be First in New Cholesterol Drug Class
Amgen Wins EU Approval to Be First in New Cholesterol Drug Class
Amgen Wins EU Approval to Be First in New Cholesterol Drug Class
Submitted by
admin
on July 21, 2015 - 10:11am
Source:
Bloomberg
News Tags:
Amgen
Europe
PCSK9 inhibitors
Repatha
Headline:
Amgen Wins EU Approval to Be First in New Cholesterol Drug Class
Do Not Allow Advertisers to Use My Personal information
